The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCAR-T 2019 | Day 1 round up: CAR-T toxicity
From the 1st International Workshop on CAR-T (iwCAR-T), held in Miami, FL, John Gribben, MD, DSc, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, Noelle Frey, MD, University of Pennsylvania, Philadelphia, PA, and David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, discuss the current updates in CAR-T toxicity. The speakers share their thoughts on managing CAR T-cell therapy-related toxicity and discuss the consensus grading scale for CRS and neurotoxicity.
